Literature DB >> 12632932

[Recombinant erythropoietins--an alternative therapy to red cell blood transfusions in infants with hereditary spherocytosis].

Magdalena Neuman-Łaniec1, Jolanta Wierzba, Ninela Irga, Eliza Wasilewska, Anna Balcerska.   

Abstract

Hereditary spherocytosis is the most frequently occurring haemolytic anaemia. Some patients manifest clinical signs during the neonatal period and require transfusion. A case of hereditary spherocytosis in neonate is presented. The use of rhEPO during the first months may be an alternative therapy to red cell transfusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12632932

Source DB:  PubMed          Journal:  Przegl Lek        ISSN: 0033-2240


  2 in total

Review 1.  A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates.

Authors:  Robert D Christensen; Hassan M Yaish; Patrick G Gallagher
Journal:  Pediatrics       Date:  2015-06       Impact factor: 7.124

2.  The use of erythropoietin-stimulating agents versus supportive care in newborns with hereditary spherocytosis: a single centre's experience.

Authors:  Jacqueline F Morrison; Ellis J Neufeld; Rachael F Grace
Journal:  Eur J Haematol       Date:  2014-04-16       Impact factor: 2.997

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.